Disseminated fusarium infection after ibrutinib therapy in chronic lymphocytic leukaemia
- 9 February 2017
- journal article
- letter
- Published by Springer Nature in Annals of Hematology
- Vol. 96 (5) , 871-872
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinibBlood, 2016
- Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy resultsBlood, 2015
- Invasive fungal infections after obinutuzumab monotherapy for refractory chronic lymphocytic leukemiaAnnals of Hematology, 2014
- European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in EuropeEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Pneumocystis Pneumonia in Patients Treated With RituximabChest, 2013
- Pneumocystis jiroveci pneumonia as an atypical presentation of X-linked agammaglobulinemiaInternational Journal of Hematology, 2009
- Fusarium Infections in Immunocompromised PatientsClinical Microbiology Reviews, 2007
- Clinical patterns of Fusarium infections in immunocompromised patientsJournal of Infection, 1994